The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study
第一作者机构：[1]Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Hematol, Sch Med, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Tinghua,Xie Yinghua,Zhao Limin,et al.The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study[J].BLOOD.2019,134:doi:10.1182/blood-2019-125739.
APA：
Zhang, Tinghua,Xie, Yinghua,Zhao, Limin,Han, Xiyao,Lu, Yingting...&Liu, Ligen.(2019).The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study.BLOOD,134,
MLA：
Zhang, Tinghua,et al."The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study".BLOOD 134.(2019)
医学